Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection

Emerging Microbes and Infections

Volumn 2, Issue , 2013, Pages

  Liu, Xuhui ^a   Li, Tao ^a   Zheng, Yufang ^a   Wong, Ka Wing ^a   Lu, Shuihua ^a   Lu, Hongzhou ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Contact; H7N9; Influenza A; Neuraminidase inhibitors; Oseltamivir

Indexed keywords

MOXIFLOXACIN; OSELTAMIVIR; PIPERACILLIN PLUS TAZOBACTAM;

ACUTE LUNG INJURY; ADULT; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FEVER; FLU LIKE SYNDROME; HOSPITAL PATIENT; HUMAN; HYPOXEMIA; INFLUENZA A; INFLUENZA VIRUS A; INFLUENZA VIRUS A H7N9; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TACHYCARDIA; TACHYPNEA; THROAT CULTURE; TREATMENT RESPONSE;

INFLUENZA A VIRUS;

EID: 84878391249     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi2013.30     Document Type: Article

References (14)

1. Webster RG. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch Virol Suppl 1997; 13: 105-113. (Pubitemid 127502136)
2. Webster RG, Bean WJ, Gorman O.T., Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152-179.
3. Li KS, Guan Y, Wang J et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004; 430: 209-213. (Pubitemid 38902429)
4. Yu Chen, Weifeng Liang, Shigui Yang et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013 April 25; doi:10.1016/S0140-6736(13)60903-60904.
5. Gao R, Cao B, Hu Y et al. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. N Engl J Med 2013 Apr 11; doi: 10.1056/NEJMoa1304459.
6. Yang F, Wang J, Jiang L et al. A fatal case caused by novel H7N9 avian influenza A virus in China. Emerg Microbes Infect 2013; 2: e19.
7. Qun Li, Lei Zhou, Minghao Zhou et al. Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. N Engl J Med 2013 Apr 24; doi: 10.1056/NEJMoa1304617.
8. Kageyama T, Fujisaki S, Takashita E et al. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro surveillance: European communicable disease bulletin 18(2013). Euro Surveill 2013; 18. pii: 20453.
9. nd ed. Beijing: NPFPC, 2013. Available at http://www.moh.gov.cn/mohgjhzs/s7952/201304/ 98ceede1daf74a45b1105f18c4e23ece.shtml.
10. Adisasmito W, Chan PK, Lee N et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis 2010; 202: 1154-1160.
11. Wen YM, Klenk HD H7N9 avian influenza virus - search and re-search. Emerg Microbes Infect 2013; 2: e18.
12. Chan PK, Lee N, Zaman M et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis 2012; 206: 1359-1366.
13. Govorkova EA, Baranovich T, Seiler P et al. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring. Antiviral Res 2013; 98: 297-304.
14. Carrat F, Vergu E, Ferguson NM et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167: 775-785. (Pubitemid 351451744)